Form 4 for CLB Core Laboratories Inc. /DE/
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-31 · accession 0000950170-24-001237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-03 | 2023-12-31 | CLB | Hill Christopher Scott | SVP, CFO | M - OptEx | $0.00 | +36.1K | 86.2K | +72% | $0 |
| D | 2024-01-03 | 2023-12-31 | CLB | Hill Christopher Scott | SVP, CFO | F - Tax | $17.66 | -13.9K | 72.4K | -16% | -$244.9K |
| D | 2024-01-03 | 2023-12-31 | CLB | Hill Christopher Scott | SVP, CFO | M - OptEx | $0.00 | -36.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-31 | M | A | 36,072 | $0.00 | 86,244 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-31 | F | D | 13,870 | $17.66 | 72,374 | D | — | — | |
| 3 | Derivative | Performance Shares | 2023-12-31 | M | D | 36,072 | $0.00 | 0 | D | $0.00 · — to — | 36,072 Common Stock | (F1) These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023. Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half. Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023. |